FCF Life Sciences
IPO Report

The FCF Life Sciences IPO Report examines recent IPO trends in the Life Sciences sector, with a strong focus on the comparison of European and US characteristics.

FCF Life Sciences
IPO Report
Share Pricing / Trading Analysis
Investor Analysis
Size Segment Analysis
Underwriter Analysis
Sub-sector Analysis
and more...
Previous
Next
FCF LIFE SCIENCES IPO REPORT
Share Pricing / Trading Analysis
Investor Analysis
Size Segment Analysis
Underwriter Analysis
Sub-sector Analysis
and more...
Previous
Next

LIFE SCIENCES RESEARCH SERIES

We constantly engage in capital markets research to identify financing trends early in the Life Sciences sector. Our FCF Life Sciences Research Series focuses on the most relevant equity markets: Venture Capital, Public Equity, Initial Public Offerings (IPO). The findings are currently published in the following publications:

Licensing Research

Recent licensing trends of European Biotech companies in China
Upcoming
Recent licensing trends of European Biotech companies in China
Upcoming

Biotech Licensing Monitor – China
-Upcoming-
Recent licensing trends of European Biotech companies in China

Other Life Sciences Researches

Recent valuations of listed MedTech companies
Upcoming
MedTech Public Equity Monitor

Life Sciences IPO Report
Recent IPO trends in the Life Sciences sector

Biotech Public Equity Monitor
Recent valuations of listed European Life Sciences companies

MedTech Public Equity Monitor
-Upcoming-
Recent valuations of listed MedTech companies

NEWS & PRESS

Scroll Up